User:PaulWicks/sandbox

(Edit: New Section) Product and Services
Original: ''As of 2018, the Ada consumer product, the Web application was available in English, German, Spanish, Portuguese, Swahili, Romanian, and French. As of September 2020, the Ada app has been downloaded 10 million times and completed 20 million symptom assessments. It is free of charge and has the highest consumer rank among similar apps. Thanks to funding from the Bill & Melinda Gates Foundation and Fondation Botnar, in November 2019, Ada launched its app in both Swahili and Romanian. ''

''In 2022 it was integrated into Scout by Sutter Health. ''

Edit:

Software
The company offers a suite of modular software as a service solutions to healthcare provider systems in multiple languages:
 * Symptom Assessment: User-facing health assessment that asks individuals to enter basic health data (e.g. demographics, smoking history) and the main complaint that is currently troubling them. Bayesian reasoning is combined with a medical knowledge database curated from the scientific literature, clinical case reports, and epidemiological data, to provide the user the most effecient sequence of followup questions that will identify the potential conditions that could be causing the issue. The assessment is available to patients via their health system's website, app or patient portal, such as Epic MyChart (REFERENCE)
 * Care Navigation: Following on from the symptom assessment, where healthcare enterprise clients have partnered with Ada, the Connect tool helps users navigate to the appropriate level of care and setting e.g. self-care, primary care, secondary care, telehealth.
 * Clinical handover: As a further degree of integration, the clinical assessment information in the Assessment and care navigation tool can be provided to clinicians via a patient's electronic health record such as Epic Systems' Hyperspace.
 * Data Insights: Reports and dashboards are generated for healthcare enterprise clients to help understand the flow of users through their system to better make strategic decisions, improve services, and identify gaps in care.

One example of the software deployed in practice is within the Sutter Health integrated care system in Northern California. Data from over 26,000 symptom assessments in the first 10 months found most users were female (67%) adults (mean of 34 years, most users between 20 - 48 years old). The most commonly presenting initial symptoms were abdominal pain (8%), cough (6%), headache (4%), and sore throat (3%), and just under half of assessments (46%) were completed outside typical physician office hours.

(Edit: New Section) Health Initiatives
In addition to the company's core business, Ada Health houses a "global health initiative" (GHI) which partners with non-governmental organizations, governments, and global health organizations such as the Bill & Melinda Gates Foundation and Fondation Botnar to widen access to digital health services in low and middle income countries such as Romania, Tanzania. and South Africa [REFERENCE HERE TO https://ada.com/press/230905-ada-supporting-mothers-in-southafrica/ In addition, a "rare disease initiative" (RDI) focusses on modeling rare diseases in their software's medical knowledge database to try and shorten the delay in diagnosis that patients often face. To date the RDI has included modeling diseases including axial spondyloarthritis, familial Mediterranean fever, lysosomal storage diseases, porphyria, and psoriatic arthritis. 

Research and publications
Independent scientific reviews of the Ada symptom checker's usability, coverage of medical conditions, accuracy in suggesting a reasonable diagnosis, and safety in making recommendations have been conducted by a number of academic researchers. These studies have found Ada to be useful in aiding diagnosis in settings including primary care, emergency care , rheumatology clinics , dermatology , and psychiatry. A 2019 retrospective study evaluated Ada DX in rare disease diagnosis. Ada's top suggestion matched the confirmed diagnosis in 89% of cases (83 of 93 cases). In more than 56% of cases, Ada provided correct disease suggestions earlier than the time of clinical diagnosis. More than 33% of patients could have been identified as having a rare disease in the first documented clinical visit. Relative to other symptom checkers Ada often has the highest degree of accuracy and safety, but as a tradeoff asks more questions than some other tools and may sometimes be more conservative in triaging patients to seek professional help over self-care.

Research by Sutter Health, with Stanford University, independently analyzed 26,646 Ada assessments, finding that Ada's triage recommendations were comparable to those of nurse-staffed telephone triage lines. [REFERENCE]

(Edit: New Section) Investors, funding and revenue
As of 2023, Ada Health has raised $189.5 million US dollars in funding from venture capital funds including Vitruvian Partners, Bertelsmann, Schroders, Farallon Capital, Red River West, as well as corporate development funds including Leaps by Bayer and Samsung Catalyst Fund and debt financing provider IPF Partners.

Ada's consumer app is non-revenue generating and does not sell data or advertise to generate income [REFERENCE FAQ]. Ada generates revenue through enterprise partnerships with healthcare systems, providers, payers/insurers, life science organizations by licensing technology for their users or on their channels. Ada has also received grants from philanthropic foundations and government funds such as the EU fund TBC [FIND REFERENCE]

Media coverage
Original: Ada has been compared to WebMD, Babylon's GP at Hand app, and Your.MD. In October 2017, when three apps were tested with symptoms from asthma, shingles, alcohol-related liver disease, and urinary tract infection, Ada performed very well; it asked about the most important symptoms and provided the best diagnoses. It produced diagrams showing which of the symptoms for each disease were present and the strength of the link, and a diagram of the percentage of people likely to have that diagnosis.

Original: In September 2020, Broadband Commission for Sustainable Development issued a report identifying Ada as of the AI solutions that have the "potential to address existing health inequalities and provide medical expertise to clinicians, health workers, and patients alike - all with the aim of improving the quality, access, and cost of healthcare delivery."

Ada & Rare diseases
Original: A 2019 retrospective study evaluated Ada DX in rare disease diagnosis. Ada's top suggestion matched the confirmed diagnosis in 89% of cases (83 of 93 cases). In more than 56% of cases, Ada provided correct disease suggestions earlier than the time of clinical diagnosis. More than 33% of patients could have been identified as having a rare disease in the first documented clinical visit.

Reception
Original: In 2020, the World Economic Forum awarded Ada and other 99 candidates as its "Technology Pioneers." Since its global launch in 2016, Ada has won several awards, such as App Promotion Summit's Fastest Growing App, Proddys Award for best Health and Fitness Product, CogX: Good Health and Well-being Award, German Brand Award, German Innovation Award, and German WELT AI User Award. ADD REFERENE https://www.axelspringer.com/en/ax-press-release/welt-awards-ai-prize-2022-for-special-achievements-and-innovations-in-the-field-of-artificial-intelligence